Description

Traumatic brain injury (TBI) affects 5.3 million Americans annually. Despite the many long-term deficits associated with TBI, there currently are no clinically available therapies that directly address the underlying pathologies

Traumatic brain injury (TBI) affects 5.3 million Americans annually. Despite the many long-term deficits associated with TBI, there currently are no clinically available therapies that directly address the underlying pathologies contributing to these deficits. Preclinical studies have investigated various therapeutic approaches for TBI: two such approaches are stem cell transplantation and delivery of bioactive factors to mitigate the biochemical insult affiliated with TBI.

Reuse Permissions
  • application/pdf

    Download count: 0

    Details

    Contributors
    Date Created
    • 2015-05-12
    Resource Type
  • Text
  • Collections this item is in
    Identifier
    • Digital object identifier: 10.4137/BMI.S20062
    • Identifier Type
      International standard serial number
      Identifier Value
      1177-2719
    Note

    Citation and reuse

    Cite this item

    This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.

    Addington, C., Dutta, D., Roussas, A. & Stabenfeldt, S. (2015). Endogenous Repair Signaling after Brain Injury and Complementary Bioengineering Approaches to Enhance Neural Regeneration. Biomarker Insights, 43. doi:10.4137/bmi.s20062

    Machine-readable links